PubMed HealthSearch

PubMed · 857706

Sperm motile efficiency.

Abstract

To provide an alternative to presently available subjective ways of measuring sperm motility which often yield inconsistent data, we devised a method for determining sperm motile efficiency with it one can express objectively the amount of active sperm movement. Using a melangeur for counting white cell, semen is diluted 20-fold in normal saline solution. With the diluted semen on Thoma's hemocytometer, spermatozoa passing its small quarter line in one minute are counted, and the value is divided by the estimated number of spermatozoa per ml. The quotient is multiplied by 100 and expressed by %/min. This shows the active movement of a spermatozoon per minute. In the present study, we measured sperm motile efficiency in 162 male sterility patients, 64 cases showed values of 49%/min or less, with a mean of 20.3%/min, 46, between 50%/min and 99%/min, with a mean of 70.1%/min; and the remaining 52 over 100%/min, with a mean of 195.9%/min. Among these there were 10 cases of successful pregnancy with a mean sperm motile efficiency of 152.7%/min, and 69.0%/min at the lowest. Our new method requiring no special equipment can easily identify active sperm movement and is easily reproducible,

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

N Ishii, S Mitsukawa, M Shirai. Sperm motile efficiency.. https://doi.org/10.1111/j.1439-0272.1977.tb01260.x

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

A quantitative study of the human cerebellum with unbiased stereological techniques.

Estimates of total number of different neuron and glial cell types in the dentate nuclei and the four major regions of the human cerebellum were obtained by new stereological methods. With the optical disector and Cavalieri methods, the total number of neurons and glial cells in the human cerebellum of five elderly men was estimated to be 105,000 x 10(6) (coefficient of variation, CV = 0.13). Of this total, the granule cells comprised 101,000 x 10(6) (CV = 0.13) and the Purkinje cells comprised 30.5 x 10(6) (CV = 0.13) of the neurons. The mean of the total number of neurons in the dentate nucleus was 5.01 x 10(6) (CV = 0.28). The average surface area of the human cerebellum was estimated to be 1160 cm2 (CV = 0.29). The rationale for the different sampling schemes used to quantify the various cell types is described.

Cell Count

Modulation of cell growth and differentiation by ceramide.

Ceramide has been suggested as an intracellular modulator of cell growth and differentiation [Okazaki, T. et al. (1990) J. Biol. Chem. 265, 15823-15831]. In this study, parameters that modulate the effects of ceramide on HL-60 cell growth and differentiation were examined. A short-chain, cell-permeable analog of ceramide, C2-ceramide, induced differentiation of HL-60 human leukemia cells and inhibited HL-60 growth in a concentration-dependent manner. The potency of C2-ceramide was modulated by the starting cell density such that the concentration of C2-ceramide producing 50% inhibition of cell growth (IC50%) ranged from 2 microM (for cells suspended at 1 x 10(5) cells/ml) to 11 microM (for cells at 8 x 10(5) cells/ml). However, the IC50% showed little variation if the concentration of C2-ceramide was expressed as fmol of C2-ceramide per 10(5) cells. Therefore, the effectiveness of C2-ceramide appeared to be primarily determined by its cellular rather than molar concentration. Binding of C2-ceramide to serum proteins resulted in a 10-fold increase in the IC50%. These results demonstrate that the biologic activity of C2-ceramide is subject to surface dilution kinetics and is sensitive to the presence of lipid-binding proteins. In these properties, ceramide behaves as a prototypic lipid second messenger/intracellular mediator.

Cell Count

Stabilization of the bioactivity of tumor necrosis factor by its soluble receptors.

The receptors for tumor necrosis factor (TNF) exist in cell-associated as well as soluble forms, both binding specifically to TNF. Since the soluble forms of TNF receptors (sTNF-Rs) can compete with the cell-associated TNF receptors for TNF, it was suggested that they function as inhibitors of TNF activity; at high concentrations, the sTNF-Rs indeed inhibit TNF effects. However, we report here that in the presence of low concentrations of the sTNF-Rs, effects of TNF whose induction depend on prolonged treatment with this cytokine are augmented, reflecting an attenuation by the sTNF-Rs of spontaneous TNF activity decay. Evidence that this stabilization of TNF activity by the sTNF-Rs follows from stabilization of TNF structure within the complexes that TNF forms with the sTNF-Rs is presented here, suggesting that the sTNF-Rs can affect TNF activity not only by interfering with its binding to cells but also by stabilizing its structure and preserving its activity, thus augmenting some of its effects.

Cell Count